Updated safety and efficacy of tazemetostat (TAZ) plus enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Abida, W.; Appleman, L. J.; Taplin, M. E.; Juárez, Á.; Zhang, L.; Chen, Y.; Gupta, N.; Saltzstein, D.
Abstract Title: Updated safety and efficacy of tazemetostat (TAZ) plus enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title: ESMO Congress 2024
Journal Title: Annals of Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2024 Sep 13-17
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-09-01
Start Page: S967
Language: English
ACCESSION: WOS:001326612902225
DOI: 10.1016/j.annonc.2024.08.1684
PROVIDER: wos
Notes: Meeting Abstract: 1603P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Wassim Abida
    154 Abida